Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and...
-
FORT LAUDERDALE, FLORIDA, April 30, 2025 (GLOBE NEWSWIRE) -- ScribeAmerica is proud to announce its participation in the 2025 Urgent Care Convention, taking place May 2-6 in Dallas, TX. The company...
-
Rapport Therapeutics to Participate in Upcoming Investor Conferences
-
AC Immune to Participate in Upcoming Investor Conferences Lausanne, Switzerland, March 4, 2025 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine...
-
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
-
THE WOODLANDS, TX, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...
-
FORT LAUDERDALE, FLORIDA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ScribeAmerica will attend the 43rd Annual J.P. Morgan Healthcare Conference this week in San Francisco. The conference remains one of the...
-
Paul J. Diaz, President and CEO, and Sam Raha, COO, Myriad Genetics, will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
-
Paul J. Diaz, President and CEO, and Sam Raha, COO, Myriad Genetics, will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
-
WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...